Retaglutide is a innovative GLP-1 receptor agonist currently under study for the treatment of type 2 diabetes. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://rajanagoy408590.bloggip.com/39195471/retaglutide-a-promising-glp-1-receptor-agonist